Sandra Richman - Concepedia

Author

Sandra Richman

Biogen (United States)

Also Known As

S Richman, S. Richman, Sandra Richman

Publications

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)

About

Sandra Richman is an author at Biogen (United States) specializing in medicine, autoimmune disease, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	375
2	Public Health	2	2	323
3	Clinical Immunology	2	2	33
4	Epidemiology	2	2	323
5	Arts	1	1	15

Sandra Richman

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Gary Bloomgren, Sandra Richman, Christophe Hotermans, New England Journal of Medicine	2012	1.2K
Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy Tatiana Plavina, Meena Subramanyam, Gary Bloomgren, Annals of Neurology	2014	427
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies Pei‐Ran Ho, Harold Koendgen, Nolan Campbell, The Lancet Neurology Systemic DiseasesDisease ProgressionAutoimmune DiseaseMedicineNeuroepidemiology	2017	310
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy Patrick Vermersch, Ludwig Kappos, Ralf Gold, Neurology	2011	198
Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1 Carmen Bozic, Sandra Richman, Tatiana Plavina, Annals of Neurology	2011	141
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study Susan Friend, Sandra Richman, Gary Bloomgren, BMC Neurology	2016	128
Outcome and survival of asymptomatic <scp>PML</scp> in natalizumab‐treated <scp>MS</scp> patients Tuan Dong‐Si, Sandra Richman, Mike P. Wattjes, Annals of Clinical and Translational Neurology	2014	124
A Novel PEGylated Interferon Beta‐1a for Multiple Sclerosis: Safety, Pharmacology, and Biology Xiao Hu, Larisa Miller, Sandra Richman, The Journal of Clinical Pharmacology	2011	122
Anti‐<scp>JC</scp> virus (<scp>JCV</scp>) antibody prevalence in the <scp>JCV</scp> Epidemiology in <scp>MS</scp> (<scp>JEMS</scp>) trial Carmen Bozic, Meena Subramanyam, Sandra Richman, European Journal of Neurology	2013	98
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy Tuan Dong‐Si, Sarah Gheuens, Amy Gangadharan, Journal of NeuroVirology	2015	95

Page 1